Sunvax Mrna Therapeutics Inc.

États‑Unis d’Amérique


 
Quantité totale PI 8
Rang # Quantité totale PI 195 414
Note d'activité PI 1,9/5.0    12
Rang # Activité PI 73 549
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

4 1
0 0
3 0
0
 
Dernier brevet 2025 - Compositions and methods for del...
Premier brevet 2023 - Ionizable lipid compounds and li...
Dernière marque 2023 - SUNVAX MRNA THERAPEUTICS
Première marque 2023 - SUNVAX MRNA THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator. Lipid nanop...
Invention Compositions and methods for delivering molecules. Compositions comprising mRNA, self-amplifying...
Invention Compositions and methods for delivering molecules. ex vivoex vivo by contacting immune cells with...
2023 P/S Lipids used in the manufacture of cosmetics, beverages, food products and food supplements for in...
Invention Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator. Lipid nanopa...
Invention Ionizable lipid compounds and lipid nanoparticle compositions. Novel ionizable lipids, compositi...
Invention Ionizable lipid compounds and lipid nanoparticle compositions. Novel ionizable lipids, compositio...